CooperVision Appoints Justin Kwan, OD, to North America Myopia Management Leadership Role


Justin Kwan, OD, FAAO

SAN RAMON, Calif.—CooperVision has named Justin Kwan, OD, FAAO, as senior manager, myopia management in its professional and academic affairs group. In this newly created role, Dr. Kwan will be responsible for supporting the growth of the company’s myopia management business across North America, according to the company’s announcement on Thursday. This includes its Brilliant Futures Myopia Management Program featuring MiSight 1 day, the first and only FDA-approved product clinically proven to slow the progression of myopia when initially prescribed for children 8 to 12 years old in the U.S.

Dr. Kwan will lead the roll-out and provide support of myopia management programs in partnership with eyecare practitioners (ECPs) across the U.S. and Canada. He will work within CooperVision to help define and develop the myopia management strategy, including key focus areas, major events, clinical papers, training plans, presentations, and marketing collateral, and ensure cross-functional alignment.

In addition to helping develop strategic plans and initiatives, Dr. Kwan will also work to further deepen relationships with ECPs, schools and colleges of optometry, and other industry leaders involved in the field, according to the announcement.

“This role requires someone who is extremely knowledgeable about myopia management and can apply that to support ECPs and wearers,” Michele Andrews, OD, senior director of North America professional and academic affairs at CooperVision, said. “We saw Justin’s passion shine through in his commitment to research and other professional engagements. Justin’s contributions will extend our Brilliant Futures Myopia Management Program, and in doing so advance the entire profession and change the lives of children and families for the better.”

Dr. Kwan has more than a decade of professional experience in both practice and educational settings. He comes to CooperVision from Professional Eye Care Center in Niles, Ill., where he served as an optometrist since 2018. Prior to that, Dr. Kwan was on faculty at the Southern California College of Optometry (SCCO). He also completed a dry eye and contact lens research fellowship at SCCO after he graduated from the University of California, Berkeley in 2009.

Dr. Kwan is editor-in-chief of Clinical and Refractive Optometry, chairs the American Academy of Optometry’s Fellows Doing Research SIG, and is the president of the Chicago North Side Optometric Society.

“Joining CooperVision at this stage is a once in a lifetime opportunity, at a time where the Brilliant Futures Myopia Management Program will help define how the profession addresses such a major public health issue,” Dr. Kwan said. “I’m looking forward to becoming part of ECPs’ teams as they grow their myopia management knowledge and practices.”